Cited by 4,769Adipokines, Inflammation, and Metabolic DiseasesAdipose Tissue and MetabolismDiabetes Treatment and Management

Inflammation and insulin resistance

Open access
Shoelson, S. E.·2006·Journal of Clinical Investigation

Abstract

Over a hundred years ago, high doses of salicylates were shown to lower glucose levels in diabetic patients. This should have been an important clue to link inflammation to the pathogenesis of type 2 diabetes (T2D), but the antihyperglycemic and antiinflammatory effects of salicylates were not connected to the pathogenesis of insulin resistance until recently. Together with the discovery of an important role for tissue macrophages, these new findings are helping to reshape thinking about how obesity increases the risk for developing T2D and the metabolic syndrome. The evolving concept of insulin resistance and T2D as having immunological components and an improving picture of how inflammation modulates metabolism provide new opportunities for using antiinflammatory strategies to correct the metabolic consequences of excess adiposity.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1172/jci29069

Cites

107 of 107 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Inflammatory signals such as tumour necrosis factor α and interleukin 6 activate serine and threonine kinases such as Iκ kinase β and jun-N terminal kinase, which have been implicated in increased serine phosphorylation of IRS1.

    “Specifically, inflammatory signals such as tumour necrosis factor α and interleukin 6 activate serine and threonine kinases such as Iκ kinase β and jun-N terminal kinase, which have been implicated in increased serine phosphor ylation of IRS1.”

    From Lipid-induced insulin resistance: unravelling the mechanism (2010) · cites this paper as [117]

  • Inflammatory signals affect cellular pathways that intersect with insulin action.

    “Mechanistically, inflammatory signals affect cellular pathways that intersect with insulin action.117”

    From Lipid-induced insulin resistance: unravelling the mechanism (2010) · cites this paper as [117]

  • Elevated levels of IL-1β are observed in pancreatic islet cells from patients with type 2 diabetes, which is increasingly being recognized as having a strong inflammatory component.

    “elevated levels of IL-1β are also observed in the pancreatic islet cells from patients with type 2 diabetes46, which is increasingly being recognized as having a strong inflammatory component47.”

    From Sterile inflammation: sensing and reacting to damage (2010) · cites this paper as [47]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

1 retracted

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Shoelson, S. E.
Affiliations
Joslin Diabetes Center (US)
Corresponding author
Shoelson, S. E.
Venue
Journal of Clinical Investigation
Published
2006-07-03
Volume
116
Issue
7
Pages
1793-1801
ISSN
0021-9738 (ISSN-L)
OpenAlex
W2152377123
Cited by
4,769
References
106
Citations by year
2026: 210 · 2025: 222 · 2024: 207 · 2023: 216 · 2022: 231 · 2021: 224 · 2020: 225 · 2019: 226 · 2018: 228 · 2017: 251 · 2016: 274 · 2015: 284 · 2014: 315 · 2013: 345 · 2012: 323
FWCI
20.08
Type
journal article
Language
en
Open access
Locations
  • Journal of Clinical Investigation (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Epidemiology › Adipokines, Inflammation, and Metabolic Diseases
  • Health Sciences › Medicine › Physiology › Adipose Tissue and Metabolism
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
Keywords
inflammation, insulin resistance, type 2 diabetes, salicylates, anti-inflammatory therapy, tissue macrophages, obesity, metabolic syndrome, adiposity
MeSH terms
Anti-Inflammatory Agents, Clinical Trials as Topic, Diabetes Mellitus, Type 2, Humans, Inflammation, Insulin Resistance, Liver, Obesity, Signal Transduction, Adipocytes

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review